Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Cancer awareness and socio-economic position: results from a population-based study in Denmark

Authors: Line Hvidberg, Anette Fischer Pedersen, Christian Nielsen Wulff, Peter Vedsted

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Differences in cancer awareness between individuals may explain variations in healthcare seeking behaviour and ultimately also variations in cancer survival. It is therefore important to examine cancer awareness and to investigate possible differences in cancer awareness among specific population subgroups. The aim of this study is to assess awareness of cancer symptoms, risk factors and perceived 5-year survival from bowel, breast, ovarian, and lung cancer in a Danish population sample and to analyse the association between these factors and socio-economic position indicators.

Methods

A population-based telephone survey was carried out among 1,000 respondents aged 30–49 years and 2,000 respondents aged 50 years and older using the Awareness and Beliefs about Cancer measure. Information on socio-economic position was obtained by data linkage through Statistics Denmark. Prevalence ratios were used to determine the association between socio-economic position and cancer awareness.

Results

A strong socio-economic gradient in cancer awareness was found. People with a low educational level and a low household income were more likely to have a lower awareness of cancer symptoms, cancer risk factors and the growing risk of cancer with age. Furthermore, men and people outside the labour force tended to be less aware of these factors than women and people within the labour force. However, women were more likely than men to lack awareness of the relationship between age and cancer risk. No clear associations were found between socio-economic position and lack of awareness of 5-year survival from bowel, breast, ovarian, and lung cancers.

Conclusions

As cancer awareness has shown to be positively associated with cancer-related behaviour, e.g. healthcare seeking, consideration must be given to tackle inequalities in cancer awareness and to address this issue in future public health strategies, which should be targeted at and tailored to the intended recipient groups.
Appendix
Available only for authorised users
Literature
1.
Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, ICBP Module 1 Working Group: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011, 377 (9760): 127-138.CrossRefPubMedPubMedCentral
2.
Storm HH, Kejs AM, Engholm G, Tryggvadottir L, Klint A, Bray F, Hakulinen T: Trends in the overall survival of cancer patients diagnosed 1964–2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix. Acta Oncol. 2010, 49 (5): 713-724.CrossRefPubMed
3.
Dalton SO, Schuz J, Engholm G, Johansen C, Kjaer SK, Steding-Jessen M, Storm HH, Olsen JH: Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: Summary of findings. Eur J Cancer. 2008, 44 (14): 2074-2085.CrossRefPubMed
4.
Coleman MP, Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Brenner H, Esteve J: Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer. 2004, 90 (7): 1367-1373.CrossRefPubMedPubMedCentral
5.
Ibfelt E, Kjaer SK, Johansen C, Hogdall C, Steding-Jessen M, Frederiksen K, Frederiksen BL, Osler M, Dalton SO: Socioeconomic position and stage of cervical cancer in Danish women diagnosed 2005 to 2009. Cancer Epidemiol Biomarkers Prev. 2012, 21 (5): 835-842.CrossRefPubMed
6.
Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP: Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer. 2013, 132 (3): 676-685.CrossRefPubMed
7.
Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD: The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012, 106 (7): 1262-1267.CrossRefPubMedPubMedCentral
8.
9.
Smith LK, Pope C, Botha JL: Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet. 2005, 366 (9488): 825-831.CrossRefPubMed
10.
Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ: Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer. 2009, 101 (Suppl 2): S92-S101.CrossRefPubMedPubMedCentral
11.
Korsgaard M, Pedersen L, Laurberg S: Delay of diagnosis and treatment of colorectal cancer–a population-based Danish study. Cancer Detect Prev. 2008, 32 (1): 45-51.CrossRefPubMed
12.
Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F: Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011, 11: 284-CrossRefPubMedPubMedCentral
13.
Brunswick N, Wardle J, Jarvis MJ: Public awareness of warning signs for cancer in Britain. Cancer Causes Control. 2001, 12 (1): 33-37.CrossRefPubMed
14.
Weinstein ND: What does it mean to understand a risk? Evaluating risk comprehension. J Natl Cancer Inst Monogr. 1999, 25 (25): 15-20.CrossRefPubMed
15.
Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Waller J, Hiom S, Wardle J: Public awareness of cancer in Britain: a population-based survey of adults. Br J Cancer. 2009, 101 (Suppl 2): S18-S23.CrossRefPubMedPubMedCentral
16.
Pedersen CB, Gotzsche H, Moller JO, Mortensen PB: The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006, 53 (4): 441-449.PubMed
17.
Butler J, Foot C, Bomb M, Hiom S, Coleman M, Bryant H, Vedsted P, Hanson J, Richards M, ICBP Working Group: The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Health Policy. 2013, 112 (1–2): 148-155.CrossRefPubMed
18.
Simon AE, Forbes LJ, Boniface D, Warburton F, Brain KE, Dessaix A, Donnelly M, Haynes K, Hvidberg L, Lagerlund M, Petermann L, Tishelman C, Vedsted P, Vigmostad MN, Wardle J, Ramirez AJ, ICBP Module 2 Working Group, ICBP Programme Board and Academic Reference Group: An international measure of awareness and beliefs about cancer: development and testing of the ABC. BMJ Open. 2012, 2 (6): 10-1136/bmjopen-2012-001758. Print 2012CrossRef
19.
Waller J, McCaffery K, Wardle J: Measuring cancer knowledge: comparing prompted and unprompted recall. Br J Psychol. 2004, 95 (Pt 2): 219-234.CrossRefPubMed
20.
21.
22.
Sundhedsstyrelsen: Sygehusbaseret overlevelse efter diagnose for otte kræftsygdomme i perioden 1998–2009. 2011, Sundhedsstyrelsen: København
23.
24.
25.
26.
Storm HH, Michelsen EV, Clemmensen IH, Pihl J: The Danish Cancer Registry–history, content, quality and use. Dan Med Bull. 1997, 44 (5): 535-539.PubMed
27.
Barros AJ, Hirakata VN: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003, 3: 21-CrossRefPubMedPubMedCentral
28.
Wardle J, Waller J, Brunswick N, Jarvis MJ: Awareness of risk factors for cancer among British adults. Public Health. 2001, 115 (3): 173-174.CrossRefPubMed
29.
Keeney S, McKenna H, Fleming P, McIlfatrick S: An exploration of public knowledge of warning signs for cancer. Eur J Oncol Nurs. 2011, 15 (1): 31-37.CrossRefPubMed
30.
von Wagner C, Good A, Whitaker KL, Wardle J: Psychosocial determinants of socioeconomic inequalities in cancer screening participation: a conceptual framework. Epidemiol Rev. 2011, 33 (1): 135-147.CrossRefPubMed
31.
Cook PA, Bellis MA: Knowing the risk: relationships between risk behaviour and health knowledge. Public Health. 2001, 115 (1): 54-61.PubMed
32.
33.
Sheikh I, Ogden J: The role of knowledge and beliefs in help seeking behaviour for cancer: a quantitative and qualitative approach. Patient Educ Couns. 1998, 35 (1): 35-42.CrossRefPubMed
34.
Lagerlund M, Hedin A, Sparen P, Thurfjell E, Lambe M: Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med. 2000, 31 (4): 417-428.CrossRefPubMed
35.
Simon AE, Waller J, Robb K, Wardle J: Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United kingdom. Cancer Epidemiol Biomarkers Prev. 2010, 19 (9): 2272-2277.CrossRefPubMedPubMedCentral
36.
Wilkinson AV, Vasudevan V, Honn SE, Spitz MR, Chamberlain RM: Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge. J Cancer Educ. 2009, 24 (1): 58-64.CrossRefPubMedPubMedCentral
37.
McCaffery K, Wardle J, Waller J: Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med. 2003, 36 (5): 525-535.CrossRefPubMed
38.
Koster B, Thorgaard C, Philip A, Clemmensen I: Sunbed use and campaign initiatives in the Danish population, 2007–2009: a cross-sectional study. J Eur Acad Dermatol Venereol. 2011, 25 (11): 1351-1355.CrossRefPubMed
39.
40.
41.
Scott SE, Grunfeld EA, Auyeung V, McGurk M: Barriers and triggers to seeking help for potentially malignant oral symptoms: implications for interventions. J Public Health Dent. 2009, 69 (1): 34-40.CrossRefPubMed
42.
Oliveria SA, Christos PJ, Halpern AC, Fine JA, Barnhill RL, Berwick M: Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol. 1999, 52 (11): 1111-1116.CrossRefPubMed
43.
Pearlman DN, Clark MA, Rakowski W, Ehrich B: Screening for breast and cervical cancers: the importance of knowledge and perceived cancer survivability. Women Health. 1999, 28 (4): 93-112.CrossRefPubMed
44.
Schueler KM, Chu PW, Smith-Bindman R: Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt). 2008, 17 (9): 1477-1498.CrossRef
45.
Sanderson SC, Waller J, Jarvis MJ, Humphries SE, Wardle J: Awareness of lifestyle risk factors for cancer and heart disease among adults in the UK. Patient Educ Couns. 2009, 74 (2): 221-227.CrossRefPubMed
46.
Waller J, Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Hiom S, Wardle J: Awareness of cancer symptoms and anticipated help seeking among ethnic minority groups in England. Br J Cancer. 2009, 101 (Suppl 2): S24-S30.CrossRefPubMedPubMedCentral
47.
48.
Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010, 46 (4): 765-781.CrossRefPubMed
49.
Breslow RA, Sorkin JD, Frey CM, Kessler LG: Americans’ knowledge of cancer risk and survival. Prev Med. 1997, 26 (2): 170-177.CrossRefPubMed
50.
Gebhardt C, Rose N, Mitte K: Fact or artefact: an item response theory analysis of median split based repressor classification. Br J Health Psychol. 2014, 19 (1): 36-51.CrossRefPubMed
51.
MacCallum RC, Zhang S, Preacher KJ, Rucker DD: On the practice of dichotomization of quantitative variables. Psychol Methods. 2002, 7 (1): 19-40.CrossRefPubMed
52.
Ekholm O, Gundgaard J, Rasmussen NK, Hansen EH: The effect of health, socio-economic position, and mode of data collection on non-response in health interview surveys. Scand J Public Health. 2010, 38 (7): 699-706.CrossRefPubMed
53.
Viswanath K, Breen N, Meissner H, Moser RP, Hesse B, Steele WR, Rakowski W: Cancer knowledge and disparities in the information age. J Health Commun. 2006, 11 (Suppl 1): 1-17.CrossRefPubMed
Metadata
Title
Cancer awareness and socio-economic position: results from a population-based study in Denmark
Authors
Line Hvidberg
Anette Fischer Pedersen
Christian Nielsen Wulff
Peter Vedsted
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-581

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue

Research article

Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study

Study protocol

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

Study protocol

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)

Research article

Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers

Research article

Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?

Research article

Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits